These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17962517)

  • 1. 4,5-Dihydro-1H-imidazol-2-yl)-[4-(4-isopropoxy-benzyl)-phenyl]-amine (RO1138452) is a selective, pseudo-irreversible orthosteric antagonist at the prostacyclin (IP)-receptor expressed by human airway epithelial cells: IP-receptor-mediated inhibition of CXCL9 and CXCL10 release.
    Ayer LM; Wilson SM; Traves SL; Proud D; Giembycz MA
    J Pharmacol Exp Ther; 2008 Feb; 324(2):815-26. PubMed ID: 17962517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a second receptor for prostacyclin on human airway epithelial cells that mediates inhibition of CXCL9 and CXCL10 release.
    Wilson SM; Sheddan NA; Newton R; Giembycz MA
    Mol Pharmacol; 2011 Mar; 79(3):586-95. PubMed ID: 21173040
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective prostacyclin receptor agonism augments glucocorticoid-induced gene expression in human bronchial epithelial cells.
    Wilson SM; Shen P; Rider CF; Traves SL; Proud D; Newton R; Giembycz MA
    J Immunol; 2009 Nov; 183(10):6788-99. PubMed ID: 19880449
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RO1138452 and RO3244794: characterization of structurally distinct, potent and selective IP (prostacyclin) receptor antagonists.
    Bley KR; Bhattacharya A; Daniels DV; Gever J; Jahangir A; O'Yang C; Smith S; Srinivasan D; Ford AP; Jett MF
    Br J Pharmacol; 2006 Feb; 147(3):335-45. PubMed ID: 16331286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation of the prostacyclin (IP) receptor antagonist RO1138452 on isolated blood vessel and platelet preparations.
    Jones RL; Wise H; Clark R; Whiting RL; Bley KR
    Br J Pharmacol; 2006 Sep; 149(1):110-20. PubMed ID: 16880763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of JAK Inhibitors on Release of CXCL9, CXCL10 and CXCL11 from Human Airway Epithelial Cells.
    Fenwick PS; Macedo P; Kilty IC; Barnes PJ; Donnelly LE
    PLoS One; 2015; 10(6):e0128757. PubMed ID: 26090665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E-ring 8-isoprostanes are agonists at EP2- and EP4-prostanoid receptors on human airway smooth muscle cells and regulate the release of colony-stimulating factors by activating cAMP-dependent protein kinase.
    Clarke DL; Belvisi MG; Hardaker E; Newton R; Giembycz MA
    Mol Pharmacol; 2005 Feb; 67(2):383-93. PubMed ID: 15528403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by salmeterol and cilomilast of fluticasone-enhanced IP-10 release in airway epithelial cells.
    Reddy PJ; Aksoy MO; Yang Y; Li XX; Ji R; Kelsen SG
    COPD; 2008 Feb; 5(1):5-11. PubMed ID: 18259970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective transcriptional down-regulation of human rhinovirus-induced production of CXCL10 from airway epithelial cells via the MEK1 pathway.
    Zaheer RS; Koetzler R; Holden NS; Wiehler S; Proud D
    J Immunol; 2009 Apr; 182(8):4854-64. PubMed ID: 19342664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nitric oxide inhibits human rhinovirus-induced transcriptional activation of CXCL10 in airway epithelial cells.
    Koetzler R; Zaheer RS; Wiehler S; Holden NS; Giembycz MA; Proud D
    J Allergy Clin Immunol; 2009 Jan; 123(1):201-208.e9. PubMed ID: 18986693
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A prostacyclin receptor antagonist inhibits the sensitized release of substance P from rat sensory neurons.
    Nakae K; Saito K; Iino T; Yamamoto N; Wakabayashi M; Yoshikawa S; Matsushima S; Miyashita H; Sugimoto H; Kiba A; Gupta J
    J Pharmacol Exp Ther; 2005 Dec; 315(3):1136-42. PubMed ID: 16109742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists.
    Antonelli A; Ferrari SM; Fallahi P; Ghiri E; Crescioli C; Romagnani P; Vitti P; Serio M; Ferrannini E
    Cytokine; 2010 Jun; 50(3):260-7. PubMed ID: 20299237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of long-chain n-3 PUFA in rhinovirus-infected cultured airway epithelial cells.
    Saedisomeolia A; Wood LG; Garg ML; Gibson PG; Wark PA
    Br J Nutr; 2009 Feb; 101(4):533-40. PubMed ID: 18631417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selexipag: a selective prostacyclin receptor agonist that does not affect rat gastric function.
    Morrison K; Ernst R; Hess P; Studer R; Clozel M
    J Pharmacol Exp Ther; 2010 Oct; 335(1):249-55. PubMed ID: 20660124
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of the human prostacyclin receptor gene is dependent on Sp1, PU.1 and Oct-1 in megakaryocytes and endothelial cells.
    Turner EC; Kinsella BT
    J Mol Biol; 2009 Feb; 386(3):579-97. PubMed ID: 19118563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression, pharmacological profile, and functional coupling of A2B receptors in a recombinant system and in peripheral blood cells using a novel selective antagonist radioligand, [3H]MRE 2029-F20.
    Gessi S; Varani K; Merighi S; Cattabriga E; Pancaldi C; Szabadkai Y; Rizzuto R; Klotz KN; Leung E; Mac Lennan S; Baraldi PG; Borea PA
    Mol Pharmacol; 2005 Jun; 67(6):2137-47. PubMed ID: 15788741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological profile of JNJ-27141491 [(S)-3-[3,4-difluorophenyl)-propyl]-5-isoxazol-5-yl-2-thioxo-2,3-dihydro-1H-imidazole-4-carboxyl acid methyl ester], as a noncompetitive and orally active antagonist of the human chemokine receptor CCR2.
    Buntinx M; Hermans B; Goossens J; Moechars D; Gilissen RA; Doyon J; Boeckx S; Coesemans E; Van Lommen G; Van Wauwe JP
    J Pharmacol Exp Ther; 2008 Oct; 327(1):1-9. PubMed ID: 18599682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacological and expression profile of the prostaglandin I(2) receptor in the rat craniovascular system.
    Myren M; Olesen J; Gupta S
    Vascul Pharmacol; 2011; 55(1-3):50-8. PubMed ID: 21749934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological characterization of MK-0974 [N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide], a potent and orally active calcitonin gene-related peptide receptor antagonist for the treatment of migraine.
    Salvatore CA; Hershey JC; Corcoran HA; Fay JF; Johnston VK; Moore EL; Mosser SD; Burgey CS; Paone DV; Shaw AW; Graham SL; Vacca JP; Williams TM; Koblan KS; Kane SA
    J Pharmacol Exp Ther; 2008 Feb; 324(2):416-21. PubMed ID: 18039958
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis.
    Okamoto Y; Folco EJ; Minami M; Wara AK; Feinberg MW; Sukhova GK; Colvin RA; Kihara S; Funahashi T; Luster AD; Libby P
    Circ Res; 2008 Feb; 102(2):218-25. PubMed ID: 17991878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.